Quarterly report pursuant to Section 13 or 15(d)

Inventories

v3.8.0.1
Inventories
 3 Months Ended
Mar. 31, 2018
Inventories  
Inventories

3.    Inventories

 

Inventories are comprised of unprocessed tissue, work-in-process, Avance® Nerve Graft, AxoGuard® Nerve Connector, AxoGuard® Nerve Protector, Avive® Soft Tissue Membrane, AcroVal® Neurosensory and Motor Testing System, AxoTouch® Two-Point Discriminator and supplies and are valued at the lower of cost (first-in, first-out) or net realizable value and consist of the following:

 

 

 

 

 

 

 

 

 

 

    

March 31,

    

December 31,

    

 

 

2018

 

2017

 

 

 

 

 

 

 

Finished goods

 

$

6,151,713

 

$

5,489,360

 

Work in process

 

 

464,392

 

 

470,187

 

Raw materials

 

 

1,436,825

 

 

1,356,395

 

Inventories

 

$

8,052,930

 

$

7,315,942

 

 

Inventories are net of write down of approximately $843,000 and $812,000 at March 31, 2018 and December 31, 2017, respectively.